Non-conjugated small molecule FRET for differentiating monomers from higher molecular weight amyloid beta species

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Ran, Chongzhao ^a   Zhao, Wei ^a   Moir, Robert D ^b   Moore, Anna ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA40 PROTEIN; AMYLOID PROTEIN; CURCUMIN; MONOMER; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN[1-40]; PEPTIDE FRAGMENT;

ANALYTIC METHOD; ARTICLE; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEASIBILITY STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; MOLECULAR WEIGHT; PROTEIN AGGREGATION; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SIGNAL DETECTION; STRUCTURAL HOMOLOGY; BIOCHEMISTRY; CHEMISTRY; DIMERIZATION; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN FOLDING;

BOVINAE;

AMYLOID BETA-PEPTIDES; BIOCHEMISTRY; CURCUMIN; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN FOLDING;

EID: 79955765954     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019362     Document Type: Article

References (28)

1. Haass C, Selkoe DJ, (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112.
2. Hardy J, Selkoe DJ, (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
3. Verwey NA, van der Flier WM, Blennow K, Clark C, Sokolow S, et al. (2009) A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem 46: 235-240.
4. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, et al. (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6: 734-746.
5. Buerger K, Frisoni G, Uspenskaya O, Ewers M, Zetterberg H, et al. (2009) Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI). Exp Gerontol 44: 579-585.
6. Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, et al. (2005) Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice. Clin Chem 51: 189-195.
7. Biancalana M, Koide S, (2010) Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta 1804: 1405-1412.
8. Groenning M, (2009) Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status. J Chem Biol.
9. Maezawa I, Hong HS, Liu R, Wu CY, Cheng RH, et al. (2008) Congo red and thioflavin-T analogs detect Abeta oligomers. J Neurochem 104: 457-468.
10. LeVine H 3rd, (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309: 274-284.
11. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, et al. (1999) Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 274: 25945-25952.
12. Biancalana M, Makabe K, Koide A, Koide S, (2009) Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies. J Mol Biol 385: 1052-1063.
13. Lindgren M, Hammarstrom P, (2010) Amyloid oligomers: spectroscopic characterization of amyloidogenic protein states. FEBS J 277: 1380-1388.
14. Lakowicz J, (1999) Principles of Fluorescence Spectroscopy: Plenum Publishing Corporation.
15. Jares-Erijman EA, Jovin TM, (2003) FRET imaging. Nat Biotechnol 21: 1387-1395.
16. Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, et al. (2005) 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci U S A 102: 17342-17347.
17. Hamley IW, (2007) Peptide fibrillization. Angew Chem Int Ed Engl 46.
18. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, et al. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280: 5892-5901.
19. Ran C, Xu X, Raymond SB, Ferrara BJ, Neal K, et al. (2009) Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits. J Am Chem Soc 131: 15257-15261.
20. Moir RD, Tseitlin KA, Soscia S, Hyman BT, Irizarry MC, et al. (2005) Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients. J Biol Chem 280: 17458-17463.
21. Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ, (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278: 11612-11622.
22. Morley JE, Farr SA, Banks WA, Johnson SN, Yamada KA, et al. (2010) A physiological role for amyloid-beta protein:enhancement of learning and memory. J Alzheimers Dis 19: 441-449.
23. Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, et al. (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5: e9505.
24. Smith NW, Annunziata O, Dzyuba SV, (2009) Amphotericin B interactions with soluble oligomers of amyloid Abeta1-42 peptide. Bioorg Med Chem 17: 2366-2370.
25. McLaurin J, Golomb R, Jurewicz A, Antel JP, Fraser PE, (2000) Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta-induced toxicity. J Biol Chem 275: 18495-18502.
26. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, et al. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14: 837-842.
27. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, et al. (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440: 352-357.
28. Venkateswarlu S, Ramachandra MS, Subbaraju GV, (2005) Synthesis and biological evaluation of polyhydroxycurcuminoids. Bioorg Med Chem 13: 6374-6380.